Adresabilitatea şi aderenţa la terapia cu agenţi biologici a pacienţilor cu psoriazis mediu şi sever | [Addressability and adherence to the biological agents therapy of the patients with moderate and severe psoriasis]

Abstract

We assert that there are approximately 440 000 patients suffering from psoriasis in Romania. The treatment cost for one individual of approximately 1 000 euro/month is covered by the National Fund of Health Insurances and there are no limitations on the number of patients suffering from moderate or severe forms of diseases who may benefit from the health program with state of the art medications, such as the biological medicines. [1] The compliance is behaviour of the patient that plays an important part in the final success or failure of each health program, as it is a prerequisite (naturally not a sufficient condition for the therapy success).